Prime Therapeutics rises to Minnesota's No. 2 largest private company as pharmacy costs rise

CEO Ken Paulus said the company ’s steady growth has largely been driven by increases in pharmacy spending, specifically for prescription medications used to treat complex conditions including oncology, autoimmune and rare diseases.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news